Zhengrong Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhengrong Zhou has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Tiansong Xie
Department of Radiology, Fudan University Shanghai Cancer Center & Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
12 shared publicationsWei Liu
Department of Radiology, Fudan University Shanghai Cancer Center & Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
9 shared publicationsZehua Zhang
Department of Radiology, Minhang Branch, Fudan University Shanghai Cancer Center, Shanghai, China
9 shared publicationsLei Chen
Department of Radiology, Minhang Branch, Fudan University Shanghai Cancer Center, Shanghai, China
8 shared publications- Lei Chen
Department of Radiology, Minhang Branch, Fudan University Shanghai Cancer Center, Shanghai, China
6 shared publications Yu Wang
Clinical and Technical Support, Philips Healthcare, Shanghai, China
6 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by AME Publishing Company in AME Case Reports
- Vol. 10, 84
A case series of radiologically misdiagnosed visceral lymphatic malformations
Visceral lymphatic malformation (LM) was rare and was easily misdiagnosed on imaging. This study aims to explore the clinicopathological and imaging findings of a series of visceral LM. The clinicopathological and imaging [computed tomography (CT) and/or magnetic resonance imaging (MRI)] findings of 11 radiologically misdiagnosed visceral LM were reviewed. The median age was 34 years old, with a sex ratio (male:female) of 1.2:1. Most were asymptomatic and found incidentally. Their locations were the lung, liver, spleen, and pancreas. They were all cystic masses, with or without septa, and mainly showed fluid attenuation on unenhanced CT (one filled with gas), hypo-signal intensity (SI) on T1WI, and hyper-SI on T2WI with/without internal hypo-SI fibrous septa. The septa showed mild to moderate enhancement. These masses were misdiagnosed as congenital pulmonary airway malformation (CPAM), hepatic mesenchymal hamartoma, splenic cyst, pancreatic intraductal papillary mucinous neoplasms (IPMN), mucinous cystadenoma, serous cystadenoma, and pancreatic ductal adenocarcinoma. They were all excised surgically. The positive rates of D2-40, CD31, and F8 staining were 100%, 100%, and 83.3%, respectively. Visceral LM were all cystic masses (multicysts or unilocular); mainly showed hypo-attenuation on unenhanced CT, hypo-SI on T1WI, and hyper-SI on T2WI with internal thin and uniform hypo-SI septa showing mild to moderate enhancement. It commonly expressed D2-40, CD31, and F8. LM should be reminded of the differentiation of visceral cystic mass.
- 1 May 2026
- Published by AME Publishing Company in AME Case Reports
- Vol. 10, 84
Open AccessA case series of radiologically misdiagnosed visceral lymphatic malformations
Visceral lymphatic malformation (LM) was rare and was easily misdiagnosed on imaging. This study aims to explore the clinicopathological and imaging findings of a series of visceral LM. The clinicopathological and imaging [computed tomography (CT) and/or magnetic resonance imaging (MRI)] findings of 11 radiologically misdiagnosed visceral LM were reviewed. The median age was 34 years old, with a sex ratio (male:female) of 1.2:1. Most were asymptomatic and found incidentally. Their locations were the lung, liver, spleen, and pancreas. They were all cystic masses, with or without septa, and mainly showed fluid attenuation on unenhanced CT (one filled with gas), hypo-signal intensity (SI) on T1WI, and hyper-SI on T2WI with/without internal hypo-SI fibrous septa. The septa showed mild to moderate enhancement. These masses were misdiagnosed as congenital pulmonary airway malformation (CPAM), hepatic mesenchymal hamartoma, splenic cyst, pancreatic intraductal papillary mucinous neoplasms (IPMN), mucinous cystadenoma, serous cystadenoma, and pancreatic ductal adenocarcinoma. They were all excised surgically. The positive rates of D2-40, CD31, and F8 staining were 100%, 100%, and 83.3%, respectively. Visceral LM were all cystic masses (multicysts or unilocular); mainly showed hypo-attenuation on unenhanced CT, hypo-SI on T1WI, and hyper-SI on T2WI with internal thin and uniform hypo-SI septa showing mild to moderate enhancement. It commonly expressed D2-40, CD31, and F8. LM should be reminded of the differentiation of visceral cystic mass.
- 26 March 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99  (1182) , 1202-1209
Clinicopathological and imaging features of pediatric adrenocortical carcinoma: compared with non-carcinoma
Objectives: To explore the differences in clinicopathological and imaging features between pediatric adrenocortical carcinoma (ACC) and non-carcinoma. Methods: The clinicopathological and imaging (CT/MR) findings of 32 children with pathologically proven adrenocortical tumors (ACT) (10 adenomas, 10 with uncertain malignant potential, and 12 carcinomas) were reviewed and compared retrospectively. Multivariate logistic regression was used further to explore the independent predictive factors for ACC and non-carcinoma. Results: The median age of children with ACC was 3 years old, with an interquartile range (IQR) of 1.813-4.375 years old. ACC was larger and more likely to be accompanied by extensive internal necrosis, calcification, and distant metastasis. ACC commonly showed a spoke-wheel enhanced pattern and peripheral fibrous septa with small blood-feeding arteries. There were significant statistical differences among these 3 groups in the maximum value of unenhanced CT, the maximum and skewness value in the venous phase, the minimum ADC value, and Ki-67 labeling index (P = .02, .003, .022, .002, and .000). The fibrous septa with small blood-feeding arteries and Ki-67 labeling index were independent predictive factors for the prediction of ACC and non-carcinoma, with P values and OR values of .038 and 15.62, and .011 and 1.16. And the AUC, the accuracy, the sensitivity, and specificity were 0.962 (95% CI, 0.828-0.998), 90.62%, 100%, and 85%, respectively. Conclusions: Pediatric ACC was larger and was commonly accompanied by extensive internal necrosis, calcification, and distant metastasis. Fibrous septa with small blood-feeding arteries and the Ki-67 labeling index were independent predictors of ACC. Advances in knowledge: Pediatric ACC showed a spoke-wheel enhanced pattern and peripheral fibrous septa with small blood-feeding arteries. The fibrous septa with small blood-feeding arteries and Ki-67 labeling index were independent predictive factors for the differentiation of ACC and non-carcinoma.
- 26 March 2026
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 99  (1182) , 1202-1209
Clinicopathological and imaging features of pediatric adrenocortical carcinoma: compared with non-carcinoma
Objectives: To explore the differences in clinicopathological and imaging features between pediatric adrenocortical carcinoma (ACC) and non-carcinoma. Methods: The clinicopathological and imaging (CT/MR) findings of 32 children with pathologically proven adrenocortical tumors (ACT) (10 adenomas, 10 with uncertain malignant potential, and 12 carcinomas) were reviewed and compared retrospectively. Multivariate logistic regression was used further to explore the independent predictive factors for ACC and non-carcinoma. Results: The median age of children with ACC was 3 years old, with an interquartile range (IQR) of 1.813-4.375 years old. ACC was larger and more likely to be accompanied by extensive internal necrosis, calcification, and distant metastasis. ACC commonly showed a spoke-wheel enhanced pattern and peripheral fibrous septa with small blood-feeding arteries. There were significant statistical differences among these 3 groups in the maximum value of unenhanced CT, the maximum and skewness value in the venous phase, the minimum ADC value, and Ki-67 labeling index (P = .02, .003, .022, .002, and .000). The fibrous septa with small blood-feeding arteries and Ki-67 labeling index were independent predictive factors for the prediction of ACC and non-carcinoma, with P values and OR values of .038 and 15.62, and .011 and 1.16. And the AUC, the accuracy, the sensitivity, and specificity were 0.962 (95% CI, 0.828-0.998), 90.62%, 100%, and 85%, respectively. Conclusions: Pediatric ACC was larger and was commonly accompanied by extensive internal necrosis, calcification, and distant metastasis. Fibrous septa with small blood-feeding arteries and the Ki-67 labeling index were independent predictors of ACC. Advances in knowledge: Pediatric ACC showed a spoke-wheel enhanced pattern and peripheral fibrous septa with small blood-feeding arteries. The fibrous septa with small blood-feeding arteries and Ki-67 labeling index were independent predictive factors for the differentiation of ACC and non-carcinoma.
- 26 March 2026
- Published by Springer Nature in European Radiology
- Vol. 36  (7) , 6204
Correction: Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients
- 26 March 2026
- Published by Springer Nature in European Radiology
- Vol. 36  (7) , 6204
Correction: Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients
- 27 February 2026
- Published by Elsevier in Clinical Radiology
- Vol. 96, 107295
The feasibility of apparent diffusion coefficient (ADC) histogram analysis in differentiating recurrences from postsurgical changes of soft tissue sarcoma
- 27 February 2026
- Published by Elsevier in Clinical Radiology
- Vol. 96, 107295
The feasibility of apparent diffusion coefficient (ADC) histogram analysis in differentiating recurrences from postsurgical changes of soft tissue sarcoma
- 16 January 2026
- Published by Elsevier in European Journal of Radiology
- Vol. 196, 112679
Spectral CT-Based habitat imaging for the prediction of occult lymph node metastasis in resectable pancreatic ductal Adenocarcinoma: Pathological validation via collagen ratio
- 16 January 2026
- Published by Elsevier in European Journal of Radiology
- Vol. 196, 112679
Spectral CT-Based habitat imaging for the prediction of occult lymph node metastasis in resectable pancreatic ductal Adenocarcinoma: Pathological validation via collagen ratio
- Open Access
- 1 October 2025
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 14  (5) , 874-877
Integrating radiomics and 3D bioprinted tumor model: the next-generation approach to improve pancreatic cancer treatment
Integrating radiomics and 3D bioprinted tumor model: the next-generation approach to improve pancreatic cancer treatment
- 1 October 2025
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 14  (5) , 874-877
Open AccessIntegrating radiomics and 3D bioprinted tumor model: the next-generation approach to improve pancreatic cancer treatment
Integrating radiomics and 3D bioprinted tumor model: the next-generation approach to improve pancreatic cancer treatment
- Open Access
- 22 February 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25  (1) , 1-11
Imaging features of epidermoid cysts in intrapancreatic spleen: a single center study of 24 patients
This study aims to investigate the imaging features of epidermoid cysts within intrapancreatic accessory spleen (ECIPAS) to benefit the differential diagnosis of pancreatic cystic lesions. We retrospectively reviewed the clinical, radiological and pathological data of 24 patients with pathologically confirmed ECIPAS. All cases underwent abdominal contrast-enhanced computed tomography (CE-CT) scans, with 4 cases further undergoing magnetic resonance cholangiopancreatography (MRCP). The imaging features of the lesions were analyzed. The majority of the patients were young to middle-aged with no apparent clinical symptoms. Over half of the masses exhibited circular, oval or unilocular architectures. On plain CT, the masses primarily displayed indistinct margins with an average diameter of 3.0 ± 1.1 cm. Nineteen lesions were situated in the pancreatic tail, 1 in the head, 1 in the head-body junction, and 3 in the body. In the arterial phases of enhanced CT scans, the lesions exhibited varying degrees of enhancement: slight enhancement (n = 11), significant enhancement (n = 5), and no discernible enhancement (n = 8) compared to pancreatic parenchyma. On MRCP scan, all four lesions showed hyperintense on T2-weighted imaging (T2WI). ECIPAS is a rare benign lesion, with nearly half exhibiting slightly uneven enhancement on contrast-enhanced CT scans. Usually, the solid-portion-enriched lesions show similar enhancement to that of the spleen, aiding in the precise preoperative diagnosis. ECIPAS can manifest in various locations within the pancreas, including the tail, head, and body. Patients may benefit from improved quality of life by avoiding unnecessary surgeries. * ECIPAS can occur not only in the pancreatic tail, but also in the pancreatic head and body. * On CE-CT scan, nearly half of ECIPAS show no marked reinforcement in arterial phase and exhibit spot-like or strip-like enhancement in venous phase while the cyst walls contain few solid portions. * Typically, the solid-portion-enriched cyst walls in ECIPAS show similar enhancement to spleen in both arterial and venous phases.
- 22 February 2025
- Published by Springer Nature in BMC Gastroenterology
- Vol. 25  (1) , 1-11
Open AccessImaging features of epidermoid cysts in intrapancreatic spleen: a single center study of 24 patients
This study aims to investigate the imaging features of epidermoid cysts within intrapancreatic accessory spleen (ECIPAS) to benefit the differential diagnosis of pancreatic cystic lesions. We retrospectively reviewed the clinical, radiological and pathological data of 24 patients with pathologically confirmed ECIPAS. All cases underwent abdominal contrast-enhanced computed tomography (CE-CT) scans, with 4 cases further undergoing magnetic resonance cholangiopancreatography (MRCP). The imaging features of the lesions were analyzed. The majority of the patients were young to middle-aged with no apparent clinical symptoms. Over half of the masses exhibited circular, oval or unilocular architectures. On plain CT, the masses primarily displayed indistinct margins with an average diameter of 3.0 ± 1.1 cm. Nineteen lesions were situated in the pancreatic tail, 1 in the head, 1 in the head-body junction, and 3 in the body. In the arterial phases of enhanced CT scans, the lesions exhibited varying degrees of enhancement: slight enhancement (n = 11), significant enhancement (n = 5), and no discernible enhancement (n = 8) compared to pancreatic parenchyma. On MRCP scan, all four lesions showed hyperintense on T2-weighted imaging (T2WI). ECIPAS is a rare benign lesion, with nearly half exhibiting slightly uneven enhancement on contrast-enhanced CT scans. Usually, the solid-portion-enriched lesions show similar enhancement to that of the spleen, aiding in the precise preoperative diagnosis. ECIPAS can manifest in various locations within the pancreas, including the tail, head, and body. Patients may benefit from improved quality of life by avoiding unnecessary surgeries. * ECIPAS can occur not only in the pancreatic tail, but also in the pancreatic head and body. * On CE-CT scan, nearly half of ECIPAS show no marked reinforcement in arterial phase and exhibit spot-like or strip-like enhancement in venous phase while the cyst walls contain few solid portions. * Typically, the solid-portion-enriched cyst walls in ECIPAS show similar enhancement to spleen in both arterial and venous phases.
- 8 February 2025
- Published by Springer Nature in European Radiology
- Vol. 35  (3) , 1451-1463
Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients
Objectives Tumor collagen is vital in chemotherapy resistance of pancreatic cancer (PC), but its non-invasive evaluation remains challenging. This study aims to investigate the association of variables derived from dual-energy CT with the collagen ratio (CR) of PC and to determine the prognostic value of CR in unresectable diseases. Materials and methods A total of 83 patients with resected PC and 71 patients with unresectable PC were enrolled. In the resected group, the correlation between the tumor CR and variables of dual-energy CT was analyzed. In the unresectable group, Cox regression analyses were conducted to investigate the prognostic value of dual-energy CT-predicted CR and other clinicoradiological indicators. Results The patients with resected PC were divided into low and high-CR sets with a threshold of 55%. In the resected group, the extracellular volume fraction calculated by the iodine concentration (ECV_IC) was the only predictor of tumor CR according to univariate and multivariate analysis (hazard ratio [HR] (95% confidence interval [CI]):1.19 [1.03–1.37]). The correlation coefficient r was 0.26 (p = 0.02) between ECV_IC and specific CR values. In the training set of unresectable PC group, ECV_IC (HR (95% CI): 0.94 (0.89–0.99), p = 0.03) and contrast-enhanced pattern (CEP) (HR (95% CI): 3.20 (1.41–7.27), p = 0.01) were independent prognostic factors for overall survival. The nomogram model was constructed and showed a good performance. Conclusion The ECV_IC is a non-invasive indicator of tumor CR in PC. The ECV_IC and CEP have the potential to predict the prognosis of unresectable PC. Key Points Question Non-invasive evaluation of tumor collagen, a vital determinant of chemotherapy resistance of pancreatic cancer, remains challenging. Findings Tumor collagen ratio can be noninvasively predicted by extracellular volume fraction based on iodine concentration. Clinical relevance The nomogram model composed of extracellular volume fraction and contrast-enhanced pattern can serve as an effective and convenient tool for stratifying the prognosis of patients with unresectable pancreatic cancer. Graphical Abstract
- 8 February 2025
- Published by Springer Nature in European Radiology
- Vol. 35  (3) , 1451-1463
Dual-energy CT extracellular volume fraction predicts tumor collagen ratio and possibly survival for inoperable pancreatic cancer patients
Objectives Tumor collagen is vital in chemotherapy resistance of pancreatic cancer (PC), but its non-invasive evaluation remains challenging. This study aims to investigate the association of variables derived from dual-energy CT with the collagen ratio (CR) of PC and to determine the prognostic value of CR in unresectable diseases. Materials and methods A total of 83 patients with resected PC and 71 patients with unresectable PC were enrolled. In the resected group, the correlation between the tumor CR and variables of dual-energy CT was analyzed. In the unresectable group, Cox regression analyses were conducted to investigate the prognostic value of dual-energy CT-predicted CR and other clinicoradiological indicators. Results The patients with resected PC were divided into low and high-CR sets with a threshold of 55%. In the resected group, the extracellular volume fraction calculated by the iodine concentration (ECV_IC) was the only predictor of tumor CR according to univariate and multivariate analysis (hazard ratio [HR] (95% confidence interval [CI]):1.19 [1.03–1.37]). The correlation coefficient r was 0.26 (p = 0.02) between ECV_IC and specific CR values. In the training set of unresectable PC group, ECV_IC (HR (95% CI): 0.94 (0.89–0.99), p = 0.03) and contrast-enhanced pattern (CEP) (HR (95% CI): 3.20 (1.41–7.27), p = 0.01) were independent prognostic factors for overall survival. The nomogram model was constructed and showed a good performance. Conclusion The ECV_IC is a non-invasive indicator of tumor CR in PC. The ECV_IC and CEP have the potential to predict the prognosis of unresectable PC. Key Points Question Non-invasive evaluation of tumor collagen, a vital determinant of chemotherapy resistance of pancreatic cancer, remains challenging. Findings Tumor collagen ratio can be noninvasively predicted by extracellular volume fraction based on iodine concentration. Clinical relevance The nomogram model composed of extracellular volume fraction and contrast-enhanced pattern can serve as an effective and convenient tool for stratifying the prognosis of patients with unresectable pancreatic cancer. Graphical Abstract
- 24 October 2024
- Published by Springer Nature in European Radiology
- Vol. 35  (5) , 2692-2701
The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer spectral computed tomography
Objectives To investigate the value of dual-layer spectral computed tomography (DLCT) parameters derived from primary tumors in predicting lymph node metastasis (LNM) of resectable pancreatic ductal adenocarcinoma (PDAC). Materials and methods In this retrospective study, patients with resectable PDAC who underwent DLCT within 2-week intervals before surgery were enrolled and randomly divided into training and validation sets at a 7:3 ratio. The patients’ clinical data, CT morphological features, and DLCT parameters were analyzed. Univariate and multivariate logistic analyses were used to identify the predictors and construct a predictive model, and receiver operator characteristic (ROC) curves were programmed to evaluate the predictive efficacy. Results We enrolled 107 patients (44 patients with LNM and 63 patients without LNM). Among all variables, iodine concentration in the venous phase, extracellular volume, and tumor size were identified as independent predictors of LNM. The nomogram model, incorporating the two DLCT parameters and the morphological feature, achieved an area under the curve (AUC) of 0.877 (95% confidence interval [CI]: 0.803–0.952) and 0.842 (95% CI: 0.707–0.977) for predicting LNM in the training and validation sets, respectively. Furthermore, the AUC of the nomogram model was greater than that of morphological features of lymph nodes in the training (AUC = 0.877 vs. 0.570) and validation (AUC = 0.842 vs. 0.583) sets. Conclusions DLCT has the potential to predict LNM in patients with resectable PDAC and show a better predictive value than morphological features of lymph nodes. Key Points Question Morphological features of lymph nodes are of limited value in detecting metastatic lymph nodes in pancreatic ductal adenocarcinoma (PDAC). Findings Dual-layer spectral computed tomography (DLCT) parameters and morphological features derived from PDAC lesions show good preoperatively predictive efficacy for lymph node metastasis. Clinical relevance The proposed DLCT-based nomogram model may serve as an effective and convenient tool for preoperatively predicting lymph node metastasis of resectable PDAC.
- 24 October 2024
- Published by Springer Nature in European Radiology
- Vol. 35  (5) , 2692-2701
The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer spectral computed tomography
Objectives To investigate the value of dual-layer spectral computed tomography (DLCT) parameters derived from primary tumors in predicting lymph node metastasis (LNM) of resectable pancreatic ductal adenocarcinoma (PDAC). Materials and methods In this retrospective study, patients with resectable PDAC who underwent DLCT within 2-week intervals before surgery were enrolled and randomly divided into training and validation sets at a 7:3 ratio. The patients’ clinical data, CT morphological features, and DLCT parameters were analyzed. Univariate and multivariate logistic analyses were used to identify the predictors and construct a predictive model, and receiver operator characteristic (ROC) curves were programmed to evaluate the predictive efficacy. Results We enrolled 107 patients (44 patients with LNM and 63 patients without LNM). Among all variables, iodine concentration in the venous phase, extracellular volume, and tumor size were identified as independent predictors of LNM. The nomogram model, incorporating the two DLCT parameters and the morphological feature, achieved an area under the curve (AUC) of 0.877 (95% confidence interval [CI]: 0.803–0.952) and 0.842 (95% CI: 0.707–0.977) for predicting LNM in the training and validation sets, respectively. Furthermore, the AUC of the nomogram model was greater than that of morphological features of lymph nodes in the training (AUC = 0.877 vs. 0.570) and validation (AUC = 0.842 vs. 0.583) sets. Conclusions DLCT has the potential to predict LNM in patients with resectable PDAC and show a better predictive value than morphological features of lymph nodes. Key Points Question Morphological features of lymph nodes are of limited value in detecting metastatic lymph nodes in pancreatic ductal adenocarcinoma (PDAC). Findings Dual-layer spectral computed tomography (DLCT) parameters and morphological features derived from PDAC lesions show good preoperatively predictive efficacy for lymph node metastasis. Clinical relevance The proposed DLCT-based nomogram model may serve as an effective and convenient tool for preoperatively predicting lymph node metastasis of resectable PDAC.
- 29 August 2024
- Published by Elsevier in European Journal of Radiology
- Vol. 181, 111710
Head-to-head comparison of contrast-enhanced CT, dual-layer spectral-detector CT, and Gd-EOB-DTPA-enhanced MR in detecting neuroendocrine tumor liver metastases
- 29 August 2024
- Published by Elsevier in European Journal of Radiology
- Vol. 181, 111710
Head-to-head comparison of contrast-enhanced CT, dual-layer spectral-detector CT, and Gd-EOB-DTPA-enhanced MR in detecting neuroendocrine tumor liver metastases